![]() |
市場調查報告書
商品編碼
1954673
全球水凝膠敷料市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察及預測(2026-2034年)Hydrogel Dressing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球水凝膠敷料市場規模為 8.29億美元,預計將從2026年的8.7007億美元成長至2034年的13.7179億美元,預測期內(2026-2034年)年複合(CAGR)成長率為 5.90%。北美地區將在2025年佔據 40.00%的市場佔有率,這主要得益於慢性傷口盛行率的上升和強勁的醫療保健支出。
水凝膠敷料由約 90%的水和不溶性親水性聚合物組成,可營造濕潤溫暖的環境,促進清創自溶解,加速傷口癒合。這些敷料廣泛用於治療糖尿病足潰瘍、壓瘡、靜脈性腿部潰瘍、燒傷、手術傷口等。根據《美國醫學會雜誌》(2023年 11月)報導,美國每年約有 160萬人患有糖尿病足潰瘍,全球每年約有 1860萬人患有糖尿病足潰瘍,這大幅推動了產品需求。
2020年,新冠肺炎疫情對市場造成了負面影響,導致患者就診量減少,傷口護理部門也暫時關閉。然而,隨著醫療服務的重新開放,2021年和2022年的收入有所恢復,市場成長也趨於正常。
市場動態
市場驅動因素
慢性及急性傷口盛行率上升
糖尿病足潰瘍、壓瘡和手術部位感染(SSI)在全球日益嚴重的負擔是推動市場成長的主要因素。手術傷口是造成醫療死亡率和醫療成本的重要因素。感染率的上升和癒合時間的延長推動對先進傷口護理解決方案(包括水凝膠敷料)的需求。
水凝膠敷料的優點
水凝膠敷料能夠維持傷口濕潤環境,促進組織再生,並透過自溶作用清除壞死組織。它們可以與局部用藥聯合使用,適用於多種類型的傷口。這些優勢提升醫生對該產品在醫療機構和家庭護理中的偏好度和產品採用率。
市場趨勢
新型水凝膠研發投入增加
目前的研發重點是利用植物萃取物、動物組織和細胞外基質等天然資源開發創新水凝膠配方。各公司投資臨床試驗,以推出先進的水凝膠產品。例如,Remedol Biomed 進行一項基於促紅血球生成素的水凝膠治療糖尿病足潰瘍的試驗。
3D 列印和奈米技術等技術推動具有增強抗菌和再生性能的先進水凝膠敷料的開發,預計這將推動市場的長期成長。
限制因子
治療成本上升及保險覆蓋範圍有限
慢性傷口護理的高昂成本仍然是一個重大障礙。例如,英國國家醫療服務體系(NHS)每年在傷口管理方面的支出約為 64.8億美元。有限的償付政策和高昂的自付費用阻礙了產品的普及,尤其是在發展中國家。這些財務挑戰可能會限制預測期內的市場擴張。
依產品劃分
市場依產品可分為非晶態敷料、浸漬敷料和片狀敷料。
由於其卓越的癒合效率和易用性,非晶態敷料預計將在2026年佔據 61.87%的市場佔有率,成為市場主導。這些敷料廣泛用於治療潰瘍和慢性傷口。
由於對 Aquacyte 水凝膠和 Solocyte 等產品的需求不斷成長,預計浸漬敷料將實現溫和成長。近年來,片狀敷料的市場佔有率顯著成長,這得益於人們對維持傷口水分平衡的護理方案的日益重視。
依材料劃分
依材料劃分,市場可分為天然材料、合成材料及半合成材料。
合成材料細分市場預計將在2026年佔據53.50%的市場佔有率,這主要得益於以聚乙二醇和聚丙烯酸為原料的有效配方。這些材料能夠創造最佳的傷口癒合環境。由於人們對生物基材料的偏好日益成長,天然材料領域預計將以更快的速度成長。
依應用領域劃分
依應用領域劃分,市場可分為糖尿病足潰瘍、壓瘡、靜脈性腿部潰瘍、燒傷和其他。
其他領域(包括手術傷口和創傷性傷口)在2024年佔據最大佔有率,這主要受全球手術部位感染(SSI)發病率上升的推動。同時,受糖尿病患者數量增加和癒合時間延長的推動,預計糖尿病足潰瘍領域在2026年將佔據25.43%的市場佔有率。預計到2034年,靜脈性腿部潰瘍和壓瘡的市場佔有率將保持穩定成長。
依最終使用者劃分
該市場依最終用戶分為醫院和診所、家庭醫療保健和其他。
預計到2026年,醫院和診所將佔據市場主導地位,市場佔有率達 61.35%,這主要得益於患者數量眾多和更優厚的償付機制。家庭醫療保健預計將實現最快成長,這主要得益於人口老化和人們對居家傷口護理的偏好。
北美
到2025年,北美市場規模達到 3.3143億美元,由於慢性傷口的高發病率和強勁的醫療保健投資,北美將繼續保持領先地位。預計2026年,美國市場規模將達到3.102億美元。
歐洲
由於成本削減措施和傷口管理方案的改進,歐洲將佔據第二大市場佔有率。預計2026年,德國市場規模將達到9,600萬美元,英國市場規模將達4,950萬美元。
亞太地區
預計亞太地區將實現最快成長。預計到2026年,中國市場規模將達到4,570萬美元,印度為3,740萬美元,日本為2,930萬美元,主要得益於糖尿病患者數量眾多以及人們健康意識的提高。
隨著醫療保健服務的改善,預計拉丁美洲以及中東和非洲地區將穩步成長。
The global hydrogel dressing market size was valued at USD 829.0 million in 2025 and is projected to grow from USD 870.07 million in 2026 to USD 1,371.79 million by 2034, registering a CAGR of 5.90% during the forecast period (2026-2034). North America dominated the market with a 40.00% share in 2025, supported by rising chronic wound prevalence and strong healthcare spending.
Hydrogel dressings consist of nearly 90% water combined with insoluble hydrophilic polymers, creating a moist and warm environment that promotes autolytic debridement and accelerates wound healing. These dressings are widely used for diabetic foot ulcers, pressure ulcers, venous leg ulcers, burns, and surgical wounds. According to the Journal of the American Medical Association (November 2023), diabetic foot ulcers affect around 1.6 million individuals annually in the U.S. and 18.6 million globally, significantly driving product demand.
The COVID-19 pandemic negatively impacted the market in 2020 due to reduced patient visits and temporary closure of wound care departments. However, revenues recovered in 2021 and 2022 as healthcare services resumed, normalizing market growth.
Market Dynamics
Market Drivers
Rising Prevalence of Chronic and Acute Wounds
The growing global burden of diabetic foot ulcers, pressure injuries, and surgical site infections (SSI) is a key growth driver. Surgical wounds contribute significantly to healthcare mortality and costs. Increasing infection rates and prolonged healing durations have led to higher demand for advanced wound care solutions, including hydrogel dressings.
Advantages of Hydrogel Dressings
Hydrogel dressings maintain moisture, support tissue regeneration, and remove necrotic tissue through autolysis. They can be used with topical medications and are suitable for multiple wound types. These benefits have increased physician preference and product adoption across hospitals and homecare settings.
Market Trends
Increasing R&D on Novel Hydrogels
Ongoing research focuses on developing innovative hydrogel formulations using natural sources such as plant extracts, animal tissues, and extracellular matrices. Companies are investing in clinical trials to introduce advanced hydrogel products. For example, Remedor Biomed Ltd. is conducting trials on erythropoietin-based hydrogels for diabetic foot ulcers.
Technologies such as 3D printing and nanotechnology are enabling the development of advanced hydrogel dressings with enhanced antimicrobial and regenerative properties, which are expected to boost long-term market growth.
Restraining Factors
High Treatment Costs and Limited Reimbursement
The high cost of chronic wound care remains a major barrier. For example, the NHS spends approximately USD 6.48 billion annually on wound management. Limited reimbursement policies and high out-of-pocket expenses restrict product adoption, particularly in developing countries. These financial challenges may limit market expansion during the forecast period.
By Product
The market is segmented into amorphous, impregnated, and sheet dressings.
The amorphous segment dominated in 2026 with a 61.87% share, owing to its superior healing efficiency and ease of application. These dressings are widely preferred for treating ulcers and chronic wounds.
Impregnated dressings are projected to grow moderately due to increasing demand for products such as AquaSite Hydrogel and SOLOSITE. Sheet dressings accounted for a considerable share in recent years, supported by rising awareness of moisture-balancing wound care solutions.
By Material
Based on material, the market is divided into natural, synthetic, and semi-synthetic.
The synthetic segment led the market in 2026 with a 53.50% share, driven by effective formulations made from polyethylene glycol and polyacrylic acid. These materials create optimal wound-healing environments. The natural segment is expected to grow at a faster pace due to increasing preference for biologically derived materials.
By Application
The market is categorized into diabetic foot ulcers, pressure ulcers, venous leg ulcers, burn injuries, and others.
The others segment (including surgical and traumatic wounds) dominated in 2024, supported by rising SSI incidence globally. Meanwhile, the diabetic foot ulcer segment accounted for 25.43% share in 2026, driven by the growing diabetic population and prolonged healing requirements. Venous leg ulcers and pressure ulcers are expected to grow steadily through 2034.
By End-user
The market is segmented into hospitals & clinics, homecare settings, and others.
The hospitals & clinics segment dominated in 2026 with a 61.35% share, due to high patient inflow and better reimbursement structures. Homecare settings are anticipated to witness the fastest growth, supported by rising geriatric populations and preference for at-home wound management.
North America
North America accounted for USD 331.43 million in 2025, maintaining leadership due to high chronic wound prevalence and strong healthcare investments. The U.S. market is projected to reach USD 310.2 million in 2026.
Europe
Europe holds the second-largest share, supported by cost-reduction initiatives and improved wound management programs. The Germany market is projected at USD 96 million in 2026, while the UK market is projected at USD 49.5 million in 2026.
Asia Pacific
Asia Pacific is expected to witness the fastest growth. The China market is projected at USD 45.7 million in 2026, India at USD 37.4 million, and Japan at USD 29.3 million, driven by a large diabetic population and increasing healthcare awareness.
Latin America and the Middle East & Africa are expected to grow steadily with improving healthcare access.
Competitive Landscape
The market is semi-consolidated with key players including 3M, Smith+Nephew, ConvaTec Group, Coloplast A/S, Integra LifeSciences, B. Braun SE, and Essity Aktiebolag. Companies focus on partnerships, acquisitions, and product innovation to expand global presence.
Notable developments include:
Conclusion
The global hydrogel dressing market is projected to grow steadily from USD 829.0 million in 2025 to USD 870.07 million in 2026, reaching USD 1,371.79 million by 2034, at a CAGR of 5.90%. Rising chronic wound prevalence, technological advancements, and expanding geriatric populations are key growth drivers. While high treatment costs and reimbursement limitations pose challenges, continuous innovation and growing healthcare investments are expected to sustain long-term market expansion worldwide.
Segmentation By Product
By Material
By Application
By End-user
By Region